​Kim represents life science companies (including both publicly held and privately owned international pharmaceutical, biotech, and medical device companies), clinical research organizations (CROs), academic medical centers, hospital systems, and non-profit research foundations in a wide range of matters related to medical research.

Biography – View PDF Bio

Associations

Bar Admissions

  • Tennessee, 2000
  • Mississippi, 1999
  • U.S. District Courts
    • Tennessee: Western
    • Mississippi: Northern, Southern
  • U.S. Court of Appeals
    • 5th Circuit
    • 6th Circuit
  • U.S. Supreme Court

Distinctions

  • Pro Bono Award, Memphis Area Legal Services, 2010

Education & Honors

  • University of Mississippi, J.D., cum laude, 1999
    • Associate Notes & Comments Editor, Mississippi Law Journal
    • Moot Court Board
  • Millsaps College, B.A., History, 1995

Experience

  • Representation of pharmaceutical, medical device, and biotech companies and various types of research organizations on issues related to medical research conducted in the United States and over 40 other countries including by way of example Austria, Australia, Belgium, Brazil, Canada, China, France, Germany, Hungary, Israel, Italy, Mexico, Netherlands, Nigeria, Peru, Poland, Russia, South Africa, South Korea, Spain, Ukraine, and the United Kingdom.   
  • Over 12 years of daily representation of pharmaceutical, medical device, and biotech companies and various types of research organizations in the review and negotiation of a wide range of medical research-related agreements such as clinical trial agreements, consent forms and HIPAA authorizations, network and consortium agreements, grant agreements and subawards, publication agreements, consulting and advisory board agreements, and service agreements.
  • Conducting the review and, as required, restructure of research-related contracting templates organization-wide. Drafting and implementing “playbooks” of acceptable fallback positions. Training of the client’s contracting team, including third party CROs, on the client’s preferred contract negotiation and escalation process and the proper use of templates and playbooks.
  • Advising clients regarding compliance with U.S. and international laws and requirements related to medical research performed in the United States and abroad including clinical trial conduct, human subject protection, data privacy, anti-bribery, independent review boards/ethic committees, and product marketing and promotion.
  • Directly interfacing with CROs and vendors on behalf of pharmaceutical and medical device companies on a broad range of issues throughout the lifecycle of a clinical trial.
  • Representation of pharmaceutical, and medical device companies including advice and services regarding grants, sponsorships, publications, and marketing and promotional activities. 
  • Review of privacy and compliance policies and programs.
  • Member of Deferred Prosecution Federal Monitor Team for a medical device company. 
  • Advising clients on contractual and legal risk utilizing insight gained from more than 8 years representing pharmaceutical and medical device companies, healthcare providers and insurance companies in civil litigation on a local and national level. 

Papers, Presentations, & Publications